Tag: ADV7103
Advicenne: ADV7103 designated orphan drug in the United States – 03/25/2024 at 09:59
(AOF) – Advicenne announces that its drug ADV7103 has obtained orphan drug designation (ODD) from the FDA for the treatment of cystinuria in the United States. The biotech specializing in…
Advicenne obtains orphan drug designation for ADV7103, in the United States – 12/13/2022 at 08:50
(AOF) – Advicenne has announced that ADV7103, its proprietary drug in phase III in the United States, has been granted orphan drug status for the treatment of distal renal tubular…